138 related articles for article (PubMed ID: 1827008)
1. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
[TBL] [Abstract][Full Text] [Related]
3. A multicenter comparison of adverse reaction profiles of isradipine and enalapril at equipotent doses in patients with essential hypertension.
Johnson BF; Eisner GM; McMahon FG; Jain AK; Rudd P; Sowers JR
J Clin Pharmacol; 1995 May; 35(5):484-92. PubMed ID: 7657848
[TBL] [Abstract][Full Text] [Related]
4. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Silagy CA; McNeil JJ; McGrath BP
Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
[TBL] [Abstract][Full Text] [Related]
5. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
6. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
Sundstedt CD; Rüegg PC; Keller A; Waite R
Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
[TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
[TBL] [Abstract][Full Text] [Related]
8. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
[TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.
Cushman WC; Cohen JD; Jones RP; Marbury TC; Rhoades RB; Smith LK
Am J Hypertens; 1998 Jan; 11(1 Pt 1):23-30. PubMed ID: 9504446
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
Perry HM; Hall WD; Benz JR; Bartels DW; Kostis JB; Townsend RR; Due DL; Peng A; Sirgo M
Am J Med; 1994 Jan; 96(1):77-86. PubMed ID: 8304366
[TBL] [Abstract][Full Text] [Related]
13. Isradipine twice daily lowers blood pressure over 24 H.
Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
[TBL] [Abstract][Full Text] [Related]
14. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
Chrysant SG; Weder AB; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Hamilton BP; Lewin AJ; Mennella RF; Kirkegaard LW; Weir MR; Weinberger MH
Am J Hypertens; 2000 Nov; 13(11):1180-8. PubMed ID: 11078178
[TBL] [Abstract][Full Text] [Related]
15. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
Applegate WB; Byington RP
Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000
[TBL] [Abstract][Full Text] [Related]
16. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
Kostis JB; Packer M; Black HR; Schmieder R; Henry D; Levy E
Am J Hypertens; 2004 Feb; 17(2):103-11. PubMed ID: 14751650
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
Williams GH; Burgess E; Kolloch RE; Ruilope LM; Niegowska J; Kipnes MS; Roniker B; Patrick JL; Krause SL
Am J Cardiol; 2004 Apr; 93(8):990-6. PubMed ID: 15081441
[TBL] [Abstract][Full Text] [Related]
18. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
[TBL] [Abstract][Full Text] [Related]
19. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
[TBL] [Abstract][Full Text] [Related]
20. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
Swartz SL; Gonasun LM; McAllister RG; Thadani U
Cardiovasc Drugs Ther; 1990 Apr; 4(2):413-7. PubMed ID: 2149512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
